| scholarly article | Q13442814 |
| P2093 | author name string | Rajendra Prasad | |
| Aman Kumar | |||
| Nandita Kakkar | |||
| Shrawan Kumar Singh | |||
| Ujjawal Sharma | |||
| Karanvir Kaushal | |||
| Sant Ram | |||
| Niti Kumari | |||
| P2860 | cites work | KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints | Q24312768 |
| Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers | Q24605342 | ||
| The role of histone demethylases in cancer therapy | Q26864687 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Chromatin modifications and their function | Q27861067 | ||
| The complex language of chromatin regulation during transcription | Q28131748 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Epigenetics in cancer | Q29547853 | ||
| Renal cell carcinoma | Q30235364 | ||
| Global histone modifications predict prognosis of resected non small-cell lung cancer. | Q33300936 | ||
| Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. | Q34128674 | ||
| Regulation of somatic cell reprogramming through inducible mir-302 expression | Q34559667 | ||
| Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro | Q35137998 | ||
| Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer | Q36185349 | ||
| Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication | Q36833415 | ||
| Cancer genetics of epigenetic genes | Q36871595 | ||
| Global levels of histone modifications predict prognosis in different cancers | Q37164151 | ||
| Histone Modification Therapy of Cancer | Q37797706 | ||
| Histone lysine methylation and demethylation pathways in cancer | Q37800638 | ||
| The emerging role of nuclear factor kappa B in renal cell carcinoma | Q37920023 | ||
| Molecular mechanisms and potential functions of histone demethylases | Q37999690 | ||
| An overview of renal cell cancer: pathology and genetics | Q38020665 | ||
| Roles of histone methyl-modifying enzymes in development and progression of cancer. | Q38096423 | ||
| Targeting histone lysine methylation in cancer | Q38314115 | ||
| Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT. | Q38899645 | ||
| Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis | Q38987172 | ||
| The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma | Q39061338 | ||
| The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer | Q39134084 | ||
| A feed-forward circuit controlling inducible NF-κB target gene activation by promoter histone demethylation | Q39657007 | ||
| Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. | Q42452150 | ||
| Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma | Q43159478 | ||
| Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development | Q43607238 | ||
| Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression | Q47141052 | ||
| Renal cell carcinoma | Q56019530 | ||
| Molecular mechanisms and potential functions of histone demethylases | Q59540864 | ||
| Extraction, purification and analysis of histones | Q80422717 | ||
| Renal cell carcinoma | Q82656838 | ||
| The KDM5 family of histone demethylases as targets in oncology drug discovery | Q87544274 | ||
| P433 | issue | 1 | |
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 8189 | |
| P577 | publication date | 2019-06-03 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications | |
| P478 | volume | 9 |
| Q90744618 | Therapeutic Targets in Telomerase and Telomere Biology of Cancers | cites work | P2860 |
Search more.